We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking TRVI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TR

Trevi Therapeutics, Inc. (TRVI) short interest & options flow

NASDAQ

TRVI heads into its August 10 earnings report with a notable analyst consensus shift as the stock trades near a multi-month high. The most striking feature of the pre-earnings setup is the direction of analyst opinion. Coverage has turned decisively constructive in the past three weeks. BMO Capital initiated with an Outperform rating and a $36 target on July 21 — the most bullish…

$13.98+0.90% 1d+3.44% 1w+0.54% 1mClose: 4 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Market cap
$1.99B
Next earnings
9 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 5 Nov 2026

ORTEX chart of Trevi Therapeutics, Inc. (TRVI) share price and short interest (% of free float), six months to November 4, 2026

TRVI news and analysis

RSS

No long-form analysis yet for TRVI. Pulse alerts and the live data picture are available on ORTEX.

Open TRVI on ORTEX →

Want the live picture for TRVI?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TRVI — free to start on ORTEX.

Sign up for free →Open TRVI on ORTEX